These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Aetiology: Koch's postulates fulfilled for SARS virus. Fouchier RA; Kuiken T; Schutten M; van Amerongen G; van Doornum GJ; van den Hoogen BG; Peiris M; Lim W; Stöhr K; Osterhaus AD Nature; 2003 May; 423(6937):240. PubMed ID: 12748632 [TBL] [Abstract][Full Text] [Related]
8. SARS--beginning to understand a new virus. Stadler K; Masignani V; Eickmann M; Becker S; Abrignani S; Klenk HD; Rappuoli R Nat Rev Microbiol; 2003 Dec; 1(3):209-18. PubMed ID: 15035025 [TBL] [Abstract][Full Text] [Related]
9. Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development. Navas-Martín SR; Weiss S J Neurovirol; 2004 Apr; 10(2):75-85. PubMed ID: 15204926 [TBL] [Abstract][Full Text] [Related]
10. Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus. Feng Y; Gao GF Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):309-27. PubMed ID: 17640731 [TBL] [Abstract][Full Text] [Related]
11. SARS coronavirus: a new challenge for prevention and therapy. Holmes KV J Clin Invest; 2003 Jun; 111(11):1605-9. PubMed ID: 12782660 [No Abstract] [Full Text] [Related]
12. Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease. Frieman M; Yount B; Agnihothram S; Page C; Donaldson E; Roberts A; Vogel L; Woodruff B; Scorpio D; Subbarao K; Baric RS J Virol; 2012 Jan; 86(2):884-97. PubMed ID: 22072787 [TBL] [Abstract][Full Text] [Related]
13. Molecular Basis of Coronavirus Virulence and Vaccine Development. Enjuanes L; Zuñiga S; Castaño-Rodriguez C; Gutierrez-Alvarez J; Canton J; Sola I Adv Virus Res; 2016; 96():245-286. PubMed ID: 27712626 [TBL] [Abstract][Full Text] [Related]
14. Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Chow KY; Hon CC; Hui RK; Wong RT; Yip CW; Zeng F; Leung FC Genomics Proteomics Bioinformatics; 2003 Nov; 1(4):247-62. PubMed ID: 15629054 [TBL] [Abstract][Full Text] [Related]
15. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology. Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500 [TBL] [Abstract][Full Text] [Related]
16. Vaccine design for severe acute respiratory syndrome coronavirus. He Y; Jiang S Viral Immunol; 2005; 18(2):327-32. PubMed ID: 16035944 [TBL] [Abstract][Full Text] [Related]
18. Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines. See RH; Petric M; Lawrence DJ; Mok CPY; Rowe T; Zitzow LA; Karunakaran KP; Voss TG; Brunham RC; Gauldie J; Finlay BB; Roper RL J Gen Virol; 2008 Sep; 89(Pt 9):2136-2146. PubMed ID: 18753223 [TBL] [Abstract][Full Text] [Related]
19. Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS. Yip MS; Leung HL; Li PH; Cheung CY; Dutry I; Li D; Daëron M; Bruzzone R; Peiris JS; Jaume M Hong Kong Med J; 2016 Jun; 22(3 Suppl 4):25-31. PubMed ID: 27390007 [No Abstract] [Full Text] [Related]
20. Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine. Lin JT; Zhang JS; Su N; Xu JG; Wang N; Chen JT; Chen X; Liu YX; Gao H; Jia YP; Liu Y; Sun RH; Wang X; Yu DZ; Hai R; Gao Q; Ning Y; Wang HX; Li MC; Kan B; Dong GM; An Q; Wang YQ; Han J; Qin C; Yin WD; Dongs XP Antivir Ther; 2007; 12(7):1107-13. PubMed ID: 18018769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]